Home News Insights Trading halts Paper trading Guide Community My account

Market calendarNext market opening

Display in USD

Loading news article.

U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Loading news article.

NeuroOne Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System | WAPE

Back All news

Newsfiscal.ai

NeuroOne Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System

Oct 30, 2026, 09:04 ET · Published

View source

Article summary

NeuroOne Medical Technologies Corporation announced the publication of initial clinical results for its OneRF® Trigeminal Nerve Ablation System in the peer-reviewed journal Pain Management.

An excerpt from the original article.

Related companies

NeuroOne Medical Technologies Corporation Common StockNMTCView stock

NeuroOne Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System

Article summary

Related companies

Analyzed by WAPE AI.

Comments —